Month: September 2016

IsoRay, Inc. Announces Launch of Newly Redesigned Patient and Clinician Focused Corporate Website

The redesigned website introduces IsoRay’s new branding and logo and offers quick and easy access to essential information that provides a comprehensive understanding of the Company’s innovative Cesium-131 products.

IsoRay, Inc. Enters Into Agreement to Settle Class Action Shareholder Litigation

If the Settlement becomes final, among other things, (i) the claims against the Defendants will be dismissed with prejudice and released,…

IsoRay Announces Fourth Quarter and Year End Fiscal 2016 Financial Results

For the fiscal year ended June 30, 2016, revenue was $4.77 million, a 4% increase compared to revenue of $4.61 million for the fiscal year ended June 30, 2015.

Scroll to top